|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/006 | (2013.01) | ||
| A61K 9/70 | (2006.01) | ||
| A61K 9/7007 | (2013.01) | ||
| A61K 47/36 | (2006.01) | ||
| A61K 47/36 | (2013.01) | ||
| A61K 31/352 | (2006.01) | ||
| A61K 31/352 | (2013.01) | ||
| A61K 31/05 | (2013.01) | ||
| A61K 31/192 | (2013.01) | ||
| A61K 31/164 | (2013.01) | ||
| A61K 31/454 | (2013.01) | ||
| A61K 31/473 | (2013.01) |
| (11) | Number of the document | 3793517 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19728321.1 |
| Date of filing the European patent application | 2019-05-15 | |
| (97) | Date of publication of the European application | 2021-03-24 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2019/062534 |
| Date | 2019-05-15 |
| (87) | Number | WO 2019/219773 |
| Date | 2019-11-21 |
| (30) | Number | Date | Country code |
| 201807942 | 2018-05-16 | GB |
| (72) |
BOYER, Scott , SE
HÜBINETTE, Fredrik , SE
SINGH, Shalini , SE
|
| (73) |
Klaria Pharma Holding AB ,
Virdings Allé 2, 754 50 Uppsala,
SE
|
| (54) | PHARMACEUTICAL FORMULATION |
| PHARMACEUTICAL FORMULATION |